Web
Analytics
The news is by your side.

GlaxoSmithKline

GSK fined in China for paying bribes

SHANGAI/LONDON: China fined GlaxoSmithKline Plc a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drugmaker.